Related Experiment Video
Updated: Oct 16, 2025

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Statins No Longer Contraindicated in Pregnancy.
1Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch : diane.aschenbrenner@gmail.com .
Statin drug labeling now allows use during pregnancy for select high-risk women. However, most women should still avoid statins due to potential risks outweighing benefits.
Area of Science:
- Cardiology
- Pharmacology
- Obstetrics
Background:
- Statins are commonly prescribed cholesterol-lowering medications.
- Historically, statin use was contraindicated during pregnancy due to potential fetal risks.
- Recent evidence suggests a re-evaluation of this contraindication in specific scenarios.
Purpose of the Study:
- To inform healthcare providers about the revised labeling of statins regarding pregnancy use.
- To delineate the specific circumstances where statins may be considered during pregnancy.
- To emphasize the general recommendation for statin avoidance in most pregnant women.
Main Methods:
- Review of updated drug safety information and clinical guidelines.
- Analysis of risk-benefit profiles for statin therapy in pregnant women.
- Consultation with cardiovascular and obstetrical experts.
Main Results:
- Statin labeling has been updated to remove the absolute contraindication for pregnancy.
- For a small subset of high-risk pregnant women, the benefits of statins may outweigh the risks.
- The majority of pregnant women do not meet the criteria for high-risk cardiovascular events and should continue to avoid statins.
Conclusions:
- The revised labeling reflects a nuanced approach to statin use in pregnancy.
- Individualized risk assessment is crucial for determining appropriate management.
- Statin therapy in pregnancy should be reserved for carefully selected high-risk individuals.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Teratogenicity

